Clinical Trials

Several new treatments for multiple sclerosis have been successfully developed over the last decade. Each of these drugs has had to undergo extensive investigation before obtaining approval for general use.

The testing of new multiple sclerosis therapies is typically done in large clinical trials and is often the culmination of many years of prior laboratory-based research and development. Occasionally, the MS clinic at Johns Hopkins will offer patients the opportunity to participate in clinical trials that are designed to test the effectiveness of new forms of therapy. Clinical trials are voluntary, and our team will only involve patients who are entirely comfortable with the process.

All clinical trials conducted here at Johns Hopkins are approved and closely monitored by the University’s Institutional Review Board. None of our MS clinic faculty have any financial interests or holdings in the various pharmaceutical companies who produce drugs used to treat MS.

If you would like study information or to participate in trials, please contact:

Karen DeBusk, RN
Research Program Coordinator
410.614.4823 voice
410.502.6736 fax
kdebusk@jhmi.edu